Lilly To Bring Forward Alzheimer’s Readout

Gamble By Rivals Biogen Is Likely Inspiration

 
• By Andrew McConaghie
Indianapolis - Circa April 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals IV - Image
Solanezumab has already failed in three Phase III trials - but Lilly hopes it could work in a preventative setting

More from R&D

More from Scrip